Psychemedics EBITDA Margin 2010-2024 | PMD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Psychemedics (PMD) over the last 10 years. The current EBITDA margin for Psychemedics as of September 30, 2024 is .
Psychemedics EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $0.02B 0 0.00%
2024-06-30 $0.02B 0 0.00%
2024-03-31 $0.02B 0 0.00%
2023-12-31 $0.02B 0 0.00%
2023-09-30 $0.02B 0 0.00%
2023-06-30 $0.03B 0 0.00%
2023-03-31 $0.03B $0.00B 3.85%
2022-12-31 $0.03B $0.00B 7.41%
2022-09-30 $0.03B $0.00B 7.41%
2022-06-30 $0.03B $0.00B 14.81%
2022-03-31 $0.03B $0.00B 15.38%
2021-12-31 $0.03B $0.00B 16.00%
2021-09-30 $0.02B $0.00B 16.67%
2021-06-30 $0.02B $0.00B 9.09%
2021-03-31 $0.02B $-0.00B -5.26%
2020-12-31 $0.02B $-0.00B -4.76%
2020-09-30 $0.03B $-0.00B -4.00%
2020-06-30 $0.03B $0.00B 3.33%
2020-03-31 $0.04B $0.01B 13.89%
2019-12-31 $0.04B $0.01B 15.79%
2019-09-30 $0.04B $0.01B 20.51%
2019-06-30 $0.04B $0.01B 22.50%
2019-03-31 $0.04B $0.01B 23.81%
2018-12-31 $0.04B $0.01B 25.58%
2018-09-30 $0.04B $0.01B 27.91%
2018-06-30 $0.04B $0.01B 28.57%
2018-03-31 $0.04B $0.01B 26.83%
2017-12-31 $0.04B $0.01B 27.50%
2017-09-30 $0.04B $0.01B 29.27%
2017-06-30 $0.04B $0.01B 32.56%
2017-03-31 $0.04B $0.02B 34.88%
2016-12-31 $0.04B $0.01B 32.50%
2016-09-30 $0.04B $0.01B 28.57%
2016-06-30 $0.03B $0.01B 20.00%
2016-03-31 $0.03B $0.00B 14.81%
2015-12-31 $0.03B $0.00B 14.81%
2015-09-30 $0.03B $0.00B 14.29%
2015-06-30 $0.03B $0.01B 17.24%
2015-03-31 $0.03B $0.01B 20.00%
2014-12-31 $0.03B $0.01B 20.00%
2014-09-30 $0.03B $0.01B 20.69%
2014-06-30 $0.03B $0.01B 21.43%
2014-03-31 $0.03B $0.01B 22.22%
2013-12-31 $0.03B $0.01B 23.08%
2013-09-30 $0.03B $0.01B 23.08%
2013-06-30 $0.03B $0.01B 24.00%
2013-03-31 $0.03B $0.01B 24.00%
2012-12-31 $0.03B $0.01B 28.00%
2012-09-30 $0.03B $0.01B 28.00%
2012-06-30 $0.03B $0.01B 28.00%
2012-03-31 $0.02B $0.01B 29.17%
2011-12-31 $0.02B $0.01B 29.17%
2011-09-30 $0.02B $0.01B 30.43%
2011-06-30 $0.02B $0.01B 27.27%
2011-03-31 $0.02B $0.01B 28.57%
2010-12-31 $0.02B $0.01B 26.32%
2010-09-30 $0.02B $0.01B 27.78%
2010-06-30 $0.02B $0.01B 27.78%
2010-03-31 $0.02B $0.00B 17.65%
2009-12-31 $0.02B $0.00B 11.76%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.014B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00